Form 4: Alkermes Director Nancy Snyderman Converts Restricted Stock Units and Sells Shares for Tax Obligations

Alkermes plc. Director Nancy Lynn Snyderman MD reported the conversion of 8,013 restricted stock units into ordinary shares and the subsequent sale of 1,924 shares to cover tax liabilities.

Summary

• On May 31, 2025, Alkermes plc. Director Nancy Lynn Snyderman MD exercised 8,013 Restricted Stock Units (RSUs), converting them into 8,013 ordinary shares.
• Following the RSU conversion, Dr. Snyderman disposed of 1,924 ordinary shares at a price of $30.61 per share.
• This disposition was made to satisfy tax withholding obligations related to the vesting of the RSUs.
• After these transactions, Dr. Snyderman directly holds 10,728 ordinary shares.
• Additionally, 20,783 ordinary shares are indirectly held by the Snyderman Trust, for which Dr. Snyderman is both the sole trustee and sole beneficiary.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine and expected insider transaction related to compensation and tax obligations, not indicative of a change in management's view of the company's prospects.

Positives

• The vesting of 8,013 Restricted Stock Units indicates the fulfillment of compensation agreements for the director.
• The conversion of RSUs into ordinary shares increases the director's direct ownership in the company prior to the tax-related sale.

Negatives

• The disposition of 1,924 shares, while for tax purposes, represents a reduction in the director's direct shareholding.

Future Outlook

N/A

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• 20,783 ordinary shares are held indirectly by the Nancy Lynn Snyderman Revocable Trust (the "Snyderman Trust"), of which the reporting person, Nancy Lynn Snyderman MD, is both the sole trustee and sole beneficiary.

Stakeholder Impact

• Shareholders: The transaction is a routine insider compensation event and is unlikely to have a significant direct impact on other shareholders.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

Keywords

Alkermes, ALKS, Form 4, Insider Transaction, Director, Restricted Stock Units, RSU Conversion, Share Disposition, Tax Withholding